During the past decade, Novartis Pharmaceuticals conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Novartis Pharmaceuticals" #1 collaborator was "Baker Heart and Diabetes Institute" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Novartis Pharmaceuticals" are "Hypertension" (32 trials), "Diabetes Mellitus, Type 2" (20 trials), "Leukemia" (4 trials), "HYPERTENSION" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Novartis Pharmaceuticals" in a lesser frequency.

Most popular intervention types in "Novartis Pharmaceuticals" are "Drug" (76 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "vildagliptin" (16 trials), "aliskiren" (11 trials), "Vildagliptin" (4 trials), "imatinib mesylate" (4 trials) and "valsartan" (3 trials). Other intervention names were less common.

The vast majority of trials in "Novartis Pharmaceuticals" are 76 trials for "All" genders.

Currently, there are NaN active trials in "Novartis Pharmaceuticals". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 74 completed trials in Novartis Pharmaceuticals, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Novartis Pharmaceuticals, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 0 trials that are defined as “Not Applicable".